EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Articles|January 6, 2006
Ingrown Toenail: How to Prevent Recurrences
A simple trick for preventing recurrence of an ingrown toenail.
Advertisement
After I have treated patients for ingrowntoenail, I suggest that they preventrecurrences by regularly filingthe central portion of the nail to keepit thin. The nail will then begin togrow more toward the center, insteadof the sides, to compensate for theloss of thickness.- Adriana Pavletic, MD
Omaha
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Care in Primary Care: Closing Diagnosis and Treatment Gaps
2
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
3
Elinzanetant Reduced Menopausal VMS Frequency by ≥50% in 67% of Women at Week 12: TMS 2026
4
Night Sweats in Midlife Women: A Q&A With Cheryl Cox Kinney, MD
5